Hauppauge, NY – According to filings with the U.S. Securities and Exchange Commission, Scienture is raising $6,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Shankar Hariharan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Scienture

Scienture Inc. is a NY based pharmaceutical research company. We are a highly experienced team of industry professionals who are passionate about developing unique specialty product concepts and solutions that bring enhanced value to patients and healthcare systems. Our assets in development are across therapeutics areas, indications and cater to different market segments. Scienture was founded by Shankar Hariharan, Ph.D., with the core purpose of using technology based concepts to design and develop novel branded drug products. During the course of his long career in the pharmaceutical industry he has successfully championed many differentiated approaches to drug development with the ultimate goal of bringing products to the market that significantly improve the standard of care, while providing broad access to patients. Our Leadership team, BOD and SAB consists of some of the most renowned names in the industry with proven experience across several facets of the business.

To learn more about Scienture, visit http://scienture.com/

Contact:
Shankar Hariharan, President and Chief Executive Officer
631-787-8575
https://www.linkedin.com/in/shankar-hariharan-3ab4b016/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved